Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-30 14:59:23 - browse：865

a person wearing blue dress conducts a finger prick test on another person in a home setting — coverage from STAT — Adobe

The last decade has seen billions of dollars flow into digital health companies that promise to improve outcomes for the 38 million Americans living with type 2 diabetes. Their products aren’t cheap, but in the long term, they pitch to health plans and employers that these digital tools will help cut health care costs by preventing serious complications like amputation and kidney failure.

A systematic review by the Peterson Health Technology Institute found, though, that digital tools used to manage diabetes with the help of finger-stick blood glucose readings don’t result in clinically meaningful improvements over standard care. As a result, they don’t reduce health care spending — they drive it up.

“Most of the solutions in this category do not deliver clinical benefits that justify their cost,” Caroline Pearson, executive director of the institute, told STAT. Despite finding that some populations may benefit, the report concludes that current evidence doesn’t support broader adoption for most products.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Burning questions for the 2024 JPM Healthcare Conference

focus

WSS

Covid vaccine financial winners and losers, from Pfizer to Novavax

3 trends to watch in health tech's hiring outlook for 2024

Supreme Court mifepristone arguments center on docs' right to sue

The biotech scorecard for Q1: 17 stock

Study says nonprofit hospitals fall short in charity care spending

Vertex Pharmaceuticals may move headquarters in Boston

entertainment

Wikipedia

leisure time

Guidelines to prevent youth baseball injuries need more muscle

A single drug, study failures leave Anavex with nothing but cash

What does generative AI mean for health care? We asked experts

Washington mulls new rules to avert another Change Healthcare

Drug repurposing or repositioning? The language matters

New weight loss drugs work. But how can they best be used?

Medicare details structure of new drug price negotiation program

Study says nonprofit hospitals fall short in charity care spending

Moonlake's readout produced a cash windfall. Risks remain

The Readout: Lenmeldy, GLP

explore

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Food as medicine: Medically tailored meals may get standardized

Will generative AI in health care meet the fate of IBM's Dr. Watson?

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Merck drug for rare lung condition set for approval in U.S.

Wikipedia

focus

focus

entertainment